» Articles » PMID: 22383878

The Invasive Capacity of HPV Transformed Cells Requires the HDlg-dependent Enhancement of SGEF/RhoG Activity

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2012 Mar 3
PMID 22383878
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A major target of the HPV E6 oncoprotein is the human Discs Large (hDlg) tumour suppressor, although how this interaction contributes to HPV-induced malignancy is still unclear. Using a proteomic approach we show that a strong interacting partner of hDlg is the RhoG-specific guanine nucleotide exchange factor SGEF. The interaction between hDlg1 and SGEF involves both PDZ and SH3 domain recognition, and directly contributes to the regulation of SGEF's cellular localization and activity. Consistent with this, hDlg is a strong enhancer of RhoG activity, which occurs in an SGEF-dependent manner. We also show that HPV-18 E6 can interact indirectly with SGEF in a manner that is dependent upon the presence of hDlg and PDZ binding capacity. In HPV transformed cells, E6 maintains a high level of RhoG activity, and this is dependent upon the presence of hDlg and SGEF, which are found in complex with E6. Furthermore, we show that E6, hDlg and SGEF each directly contributes to the invasive capacity of HPV-16 and HPV-18 transformed tumour cells. These studies demonstrate that hDlg has a distinct oncogenic function in the context of HPV induced malignancy, one of the outcomes of which is increased RhoG activity and increased invasive capacity.

Citing Articles

Bioinformatics Analysis of Human Papillomavirus 16 Integration in Cervical Cancer: Changes in MAGI-1 Expression in Premalignant Lesions and Invasive Carcinoma.

Catalan-Castorena O, Garibay-Cerdenares O, Illades-Aguiar B, Castillo-Sanchez R, Zubillaga-Guerrero M, Leyva-Vazquez M Cancers (Basel). 2024; 16(12).

PMID: 38927930 PMC: 11202195. DOI: 10.3390/cancers16122225.


Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.

Dizanzo M, Bugnon Valdano M, Basukala O, Banks L, Gardiol D BMC Cancer. 2022; 22(1):1015.

PMID: 36153517 PMC: 9509620. DOI: 10.1186/s12885-022-10105-5.


ARHGEF26 enhances Salmonella invasion and inflammation in cells and mice.

Bourgeois J, Wang L, Rabino A, Everitt J, Alvarez M, Awadia S PLoS Pathog. 2021; 17(7):e1009713.

PMID: 34242364 PMC: 8294491. DOI: 10.1371/journal.ppat.1009713.


Double inhibition and activation mechanisms of Ephexin family RhoGEFs.

Zhang M, Lin L, Wang C, Zhu J Proc Natl Acad Sci U S A. 2021; 118(8).

PMID: 33597305 PMC: 7923574. DOI: 10.1073/pnas.2024465118.


Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare.

Zubor P, Dankova Z, Kolkova Z, Holubekova V, Brany D, Mersakova S Cancers (Basel). 2020; 12(5).

PMID: 32443784 PMC: 7281750. DOI: 10.3390/cancers12051292.


References
1.
Gardiol D, Kuhne C, Glaunsinger B, Lee S, Javier R, Banks L . Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene. 1999; 18(40):5487-96. DOI: 10.1038/sj.onc.1202920. View

2.
Budnik V, Koh Y, Guan B, Hartmann B, Hough C, Woods D . Regulation of synapse structure and function by the Drosophila tumor suppressor gene dlg. Neuron. 1996; 17(4):627-40. PMC: 4661176. DOI: 10.1016/s0896-6273(00)80196-8. View

3.
Bilder D, Li M, Perrimon N . Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science. 2000; 289(5476):113-6. DOI: 10.1126/science.289.5476.113. View

4.
Barbosa M, Schlegel R . The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene. 1989; 4(12):1529-32. View

5.
Gardiol D, Galizzi S, Banks L . Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation. J Gen Virol. 2002; 83(Pt 2):283-289. DOI: 10.1099/0022-1317-83-2-283. View